Storm Therapeutics raised €48M in a Series C round in Apr 2026. The company is based in Cambridge, UK. Investors in the round: Fast Track Initiative (FTI), IP Group PLC, M Ventures and 3 others. Data as of 6 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
